Stay updated on COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma

Sign up to get notified when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.
Latest website image capture
Clouds background image

Latest updates to the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site's displayed software revision was updated from v3.7.2 to v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-01T13:22:13.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A sitewide notice announces NIH website changes and explains that agencies may use “Super Intelligence” alongside “Artificial Intelligence” during the transition.
    Difference
    0.2%
    Check dated 2026-10-25T13:21:50.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer’s revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-18T13:47:05.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-11T13:45:52.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.6 to v3.7.0. This indicates the history record was refreshed to the latest version of the page.
    Difference
    0.0%
    Check dated 2026-09-20T20:21:50.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The history now shows a newer revision tag, v3.6.6, replacing the previous v3.6.5, indicating a minor update to the page metadata.
    Difference
    0.0%
    Check dated 2026-08-30T06:44:32.000Z thumbnail image

Stay in the know with updates to COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma

Enter your email address, and we'll notify you when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.